GB889309A - 17-carboxyalkylated 3-oxygenated 6-methyl-androsten-17-ol lactones and intermediates therefor - Google Patents
17-carboxyalkylated 3-oxygenated 6-methyl-androsten-17-ol lactones and intermediates thereforInfo
- Publication number
- GB889309A GB889309A GB42034/59A GB4203459A GB889309A GB 889309 A GB889309 A GB 889309A GB 42034/59 A GB42034/59 A GB 42034/59A GB 4203459 A GB4203459 A GB 4203459A GB 889309 A GB889309 A GB 889309A
- Authority
- GB
- United Kingdom
- Prior art keywords
- methyl
- compounds
- general formula
- compound
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
The invention comprises compounds of the general formulae <FORM:0889309/IV (b)/1> wherein Z represents an ethylene or vinylene radical, X represents a carbonyl or b -hydroxymethylene radical, and M represents hydrogen or an alkali metal or an ammonium radical, 3b - acetoxy - 17a - (3 - acetoxypropyl) - 5a , 6a - epoxy - androstan - 17b - ol, 3b , 5a , 17b - tri - hydroxy - 17a - (3 - hydroxypropyl) - 6b - methyl - androstane and 17a -(2-carboxyethyl)-5a , 17b -dihydroxy-6b -methyl-androstan-3-one lactone. The 6b -methyl compounds of the above general formuls may be prepared by reacting an appropriate 17a -carboxy-alkylated androst-5-ene-3b ,17b -diol of the lactonic general formula <FORM:0889309/IV (b)/2> with lithium aluminium hydride to form the corresponding triol, diesterifying the triol (the 17b -hydroxy group being sterically hindered), converting the diester to the corresponding 5,6-epoxy compound with perbenzoic acid, treating the 5,6-epoxy compound to open the epoxy ring and cleaving the ester groups with methyl magnesium bromide to form 6-methyl-3b ,5a ,17b -triol having at the 17a -position the group -Z-CH2OH, wherein Z has the above significance, oxidising this compound with chromic acid to form a carboxyl group which lactonises with the 17b -hydroxyl group, heating this compound with finely-divided magnesium-silica gel in a solvent medium to form a 6b -methyl lactone of the first general formula above, wherein X represents a carbonyl group and the double bond is in the 4(5)-position, and when required, reducing this compound with sodium borohydride to form the corresponding compound wherein X represents the hydroxymethylene radical. The 6-methyl-5-en-3b -ols of the invention are prepared by treating compounds of the general formula <FORM:0889309/IV (b)/3> wherein m is 0 or 1, with a Grignard reagent and then carbon dioxide to form the corresponding 17a -carboxy-alkynyl compound, and then hydrogenating selectively to produce compounds in which Z represents a vinylene radical or an ethylene radical using as a catalyst palladium on calcium carbonate or palladium on charcoal, respectively, as the hydrogenation catalyst. The 6a -methyl-3-oxo compounds of the invention having the general formula <FORM:0889309/IV (b)/4> wherein Z has the above significance, are prepared by oxidising according to Oppenauer the corresponding 3b -hydroxy-6b -methyl compounds and, if necessary, reducing the resulting 6a -methyl-3-oxo compounds with sodium borohydride to form 3b -hydroxy-6a -methyl compounds of the general formula <FORM:0889309/IV (b)/5> wherein Z has the above significance. The latter compounds may be converted to the corresponding 3-keto-6-methyl-5(6)-compounds by oxidising with chromium trioxide in acetone. The lactones of the first general formula above may be contacted with aqueous alkali to form alkali metal salts of the corresponding hydroxy acids of the second general formula above from which the free acids may be obtained by a brief exposure to a proton source. Detailed examples are given. 17a - Alkynyl - 6 - methylandrost - 5 - ene - 3b ,-17b -diols of the general formula <FORM:0889309/IV (b)/6> wherein m is 0 or 1, are prepared by condensing 3b - hydroxy - 6 - methylandrost - 5 - en - 17 - one with acetylene or propargyl bromide.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US889309XA | 1958-12-11 | 1958-12-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB889309A true GB889309A (en) | 1962-02-14 |
Family
ID=22214350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB42034/59A Expired GB889309A (en) | 1958-12-11 | 1959-12-10 | 17-carboxyalkylated 3-oxygenated 6-methyl-androsten-17-ol lactones and intermediates therefor |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB889309A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3470162A (en) * | 1965-12-15 | 1969-09-30 | Syntex Corp | 3-tetrahydropyranyl ethers of steroidal aldosterone antagonists |
-
1959
- 1959-12-10 GB GB42034/59A patent/GB889309A/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3470162A (en) * | 1965-12-15 | 1969-09-30 | Syntex Corp | 3-tetrahydropyranyl ethers of steroidal aldosterone antagonists |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1096762A (en) | Processes for preparing steroids compounds and the compounds when thus prepared | |
Nozoe et al. | 1, 3-DIAZAZULENE | |
GB1242194A (en) | A new oestratriol and a process for its manufacture | |
GB889309A (en) | 17-carboxyalkylated 3-oxygenated 6-methyl-androsten-17-ol lactones and intermediates therefor | |
GB1141772A (en) | 13-alkylgonahexaenes | |
ES301833A1 (en) | A procedure for the preparation of 19-alkil-steroids (Machine-translation by Google Translate, not legally binding) | |
Barton | The Stereochemistry of Santonin, β-Santonin, and Artemisin | |
ES289304A1 (en) | Procedure for the preparation of amino-steroids (Machine-translation by Google Translate, not legally binding) | |
GB1141856A (en) | 19-nor-4,5-seco-steroids | |
GB1130052A (en) | Improvements in or relating to steroids and intermediates for the production thereof | |
Seta et al. | Biochemical Studies on “Bakanae” Fungus. Part 45: Chemical Structure of Gibberellins. Part XII | |
IE36592L (en) | Pregnane derivatives. | |
GB646828A (en) | Process for preparing artificial oestrogenic compounds and products obtained thereby | |
GB1375357A (en) | ||
GB1145063A (en) | Improvements in or relating to novel steroids and the manufacture thereof | |
GB803373A (en) | Dehydrogenation catalyst and a process for its production | |
GB992370A (en) | Improvements in or relating to androstenone derivatives | |
GB897986A (en) | New cyclopentanophenanthrene compounds and process for the production thereof | |
GB746988A (en) | Preparation of 17-formyl steroids | |
ES374961A1 (en) | Procedure for obtaining androstan derivatives. (Machine-translation by Google Translate, not legally binding) | |
GB889311A (en) | Androstenol derivatives | |
ES401765A1 (en) | 17beta-tetrahydropyran-4-yloxy- steroids | |
GB1070112A (en) | Improvements in or relating to steroid 20-ethers | |
GB1047709A (en) | 19-halo androstane compounds and process for their production | |
ES473544A1 (en) | New procedure for synthesis of valerate of diflucortolone. (Machine-translation by Google Translate, not legally binding) |